BCAX
Bicara Therapeutics Inc.Company with tickers: BCAX
CIK
2023658
CUSIP
055477103
Shares Outstanding
65,703,866
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $41,788,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Research & Development | — | ||||
| Operating Income | $-41,788,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-36,846,000 | USD | 2025-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-0.68 | USD/shares | 2025-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-0.68 | USD/shares | 2025-03-31 | 10-Q | 2026-05-11 |